⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACHV News
Achieve Life Sciences, Inc.
Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026
globenewswire.com
ACHV
Form 8-K
sec.gov
LSTA
TARS
ACHV
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
globenewswire.com
TARS
LSTA
ACHV
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
globenewswire.com
ACHV
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
globenewswire.com
ACHV
Form 8-K
sec.gov
ACHV
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
globenewswire.com
ACHV
Smoking Cessation Drug Pipeline Analysis 2026: Clinical Trials, Emerging Therapies, and Key Companies | Phase 2 Momentum and Personalized Care Drive Growth
globenewswire.com
ACHV
PFE
Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026
globenewswire.com
ACHV
Achieve Publishes New Online Guidance for Freedom Debt Relief and Achieve Customers
prnewswire.com
ACHV